MRK Competitors & Alternatives
Compare Merck & Company Inc with similar stocks in the same industry
Drug Manufacturers - General
MRK
Main Stock$147.24
Tradestie Score
43
Market Cap
$225.13B
P/E Ratio
119.0
Revenue Growth
0.1%
Analyst Upside
+7.7%
Top Competitors
18 stocks in Drug Manufacturers - General| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
JNJ
Johnson & Johnson
|
$267.61
|
$448.07B | 39.1 | 59 | Compare |
|
ABBV
ABBVIE INC.
|
$285.19
|
$431.71B | 80.5 | 44 | Compare |
|
PG
Procter & Gamble Company
|
$165.59
|
$358.52B | 24.1 | 26 | Compare |
|
NVO
Novo-Nordisk A/S
|
$39.43
|
$262.92B | 9.6 | 49 | Compare |
|
AZN
AstraZeneca PLC
|
$172.57
|
$261.56B | 25.2 | 46 | Compare |
|
NVS
Novartis AG
|
$156.27
|
$254.99B | 23.3 | 36 | Compare |
|
VZ
Verizon Communications
|
$45.20
|
$184.80B | 11.3 | 59 | Compare |
|
AMGN
Amgen Inc
|
$447.28
|
$160.70B | 27.2 | 35 | Compare |
|
PFE
Pfizer Inc.
|
$30.42
|
$154.70B | 39.3 | 35 | Compare |
|
GILD
Gilead Sciences Inc
|
$157.19
|
$137.92B | - | 43 | Compare |
More MRK Analysis
Data updated: Oct 23, 2026 | Industry: Drug Manufacturers - General (SIC 2834)
18 stocks in this industry